Inflammatory Bowel Disease With Chronic Kidney Disease and Acute Kidney Injury.
Mengyi Liu, Yanjun Zhang, Ziliang Ye...
https://pubmed.ncbi.nlm.nih.gov/37572855/Actively Recruiting
Led by Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji · Updated on 2026-05-18
6000
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are investigating how often kidney problems occur in adults with inflammatory bowel disease IBD, such as Crohns disease and ulcerative colitis, compared to adults without IBD. This observational study aims to better understand kidney complications in IBD patients, which are often overlooked despite being potentially serious. The study will include about 6,000 participants, half with confirmed IBD and half without, to serve as a control group. Participants will undergo regular clinical assessments including routine blood and urine tests, urinalysis with albumin-to-creatinine ratio measurement, and abdominal ultrasound to examine the kidneys and urinary tract. These tests will be repeated every three to six months. IBD patients will also have their disease activity measured using clinical indices like the Total Mayo Score and Crohns Disease Activity Index, along with fecal calprotectin levels to assess inflammation. During the study, participants will complete questionnaires and undergo laboratory tests and imaging at baseline and follow-up visits approximately every three months, for up to six months. Researchers will track kidney function and assess links between kidney problems, IBD activity, treatments, and other health conditions. The main outcome is the prevalence of kidney dysfunction in IBD patients compared to the general population. The study will help improve early detection and management of kidney disease in people with IBD.
CONDITIONS
Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)
K
Krzysztof Jaroń, MD, MPharm
K
Konrad Lewandowski, Associate/Assistant Professor
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
Lead Sponsor
Poznan University of Medical Sciences
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Baseline assessment
Participants undergo routine clinical evaluation including blood and urine tests and abdominal ultrasound to assess kidney function and detect renal complications.
1 baseline visit (in-person)
Duration - Up to 6 months
Participants are monitored with routine blood and urine tests and abdominal ultrasound approximately every 3 months to evaluate renal function and inflammatory bowel disease activity over time.
Visits every 3 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Mengyi Liu, Yanjun Zhang, Ziliang Ye...
https://pubmed.ncbi.nlm.nih.gov/37572855/K L Lapane, A F Jakiche, D Sugano...
https://pubmed.ncbi.nlm.nih.gov/9576453/Hannah Gordon, Johan Burisch, Pierre Ellul...
https://pubmed.ncbi.nlm.nih.gov/37351850/Hequn Wang, Lei Shi, Jia Qin...
https://pubmed.ncbi.nlm.nih.gov/24788236/Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
Lead Sponsor
Poznan University of Medical Sciences
Collaborating Sponsor